NEW YORK (GenomeWeb News) – Qiagen said Friday that a US district court has dismissed an antitrust suit that Third Wave Technologies filed against it last year as part of an ongoing legal battle over human papillomavirus testing technology.
 
Qiagen said that the US District Court for the Western District of Wisconsin has granted its Qiagen Gaithersburg subsidiary, formerly Digene, summary judgment on the antitrust counterclaims.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.